Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.4K Sell
511
-51
-9% -$4.9K ﹤0.01% 1655
2026
Q2
$53.7K Sell
562
-7,194
-93% -$691K ﹤0.01% 1522
2026
Q1
$804K Sell
7,756
-4,247
-35% -$482K 0.04% 424
2025
Q4
$1.21M Buy
12,003
+11,804
+5,932% +$1.28M 0.05% 326
2025
Q3
$24.6K Buy
199
+2
+1% +$248 ﹤0.01% 1477
2025
Q2
$23.6K Buy
197
+4
+2% +$534 ﹤0.01% 1422
2025
Q1
$28.5K Buy
193
+10
+5% +$1.53K ﹤0.01% 1319
2024
Q4
$29.6K Buy
183
+22
+14% +$3.6K ﹤0.01% 1309
2024
Q3
$26.2K Buy
+161
New +$23.9K ﹤0.01% 1346

Other funds holding CLX

BFC Planning's CLX Position: Q3 2026 in Review

BFC Planning reduced its Clorox (CLX) stake by 9.1% in Q3 2026, selling an estimated $4.9K and leaving 511 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

BFC Planning first reported a position in CLX in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.21M in Q4 2025. 857 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • BFC Planning held 511 shares of Clorox worth $41.4K as of Q3 2026.
  • BFC Planning sold 51 Clorox shares in Q3 2026, an estimated $4.9K.
  • Clorox made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1655 holding.
  • BFC Planning first reported a position in Clorox in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Clorox position peaked at $1.21M in Q4 2025.
  • 857 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.